Adam Kalbermatten
President & CEOMr. Adam Kalbermatten has been President of KORU Medical Systems, Inc. from March 15, 2026 and serves as its Chief Executive Officer since July 1, 2026. He was Chief Commercial Officer of KORU Medical Systems, Inc. from July 28, 2025 until July 1, 2026. He joined KORU Medical in 2025 from Becton Dickinson (BD), where he served as Vice President and General Manager of Advanced Drug Delivery Systems, leading growth initiatives across the injectable drug delivery platform. Prior to BD, he served as Chief Executive Officer of ZebraSci, a specialized provider of analytical and drug device combination product development services to pharmaceutical companies, where he led a successful turnaround and growth strategy resulting in an eventual acquisition of ZebraSci by BD. He also held global leadership roles at Terumo Medical Corporation, including Worldwide Director of Marketing and Worldwide Director of Business Development, where he helped shape the company’s global drug delivery strategy. He holds a Bachelor of Engineering in Mechanical Engineering and a Master of Engineering in Engineering Management from Stevens Institute of Technology and an MBA with concentrations in Finance and Healthcare from Columbia Business School.
Positions
- Company NameKORU Medical Systems, Inc.Stock CodeKRMDPositionPresident & CEOColleagues
- RJR. John FletcherIndependent Chairman of the Board
- TAThomas AdamsCFO, Secretary & Treasurer
- CPChristopher PazdanChief Operating Officer
- ESEric SchillerChief Technology Officer
- SMShahriar MatinIndependent Director
- RARobert A. CascellaIndependent Director
- JMJoseph Martin MankoLead Independent Director
- LMLinda M. TharbyDirector
